{"id":61145,"date":"2023-12-08T20:24:55","date_gmt":"2023-12-08T11:24:55","guid":{"rendered":"https:\/\/monolith.law\/cs\/?p=61145"},"modified":"2024-03-30T23:32:53","modified_gmt":"2024-03-30T14:32:53","slug":"pmd-act-administrative-action","status":"publish","type":"post","link":"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action","title":{"rendered":"Jak\u00e1 je situace s administrativn\u00edmi sankcemi za poru\u0161en\u00ed 'Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch'? Vysv\u011btlen\u00ed v\u010detn\u011b p\u0159\u00edklad\u016f"},"content":{"rendered":"\n<p>V r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (\u85ac\u6a5f\u6cd5) byly ji\u017e d\u0159\u00edve stanoveny spr\u00e1vn\u00ed sankce, jako jsou p\u0159\u00edkazy k vylep\u0161en\u00ed podnik\u00e1n\u00ed pro v\u00fdrobce a prodejce l\u00e9\u010div a dal\u0161\u00edch produkt\u016f, nebo zru\u0161en\u00ed povolen\u00ed k v\u00fdrob\u011b a prodeji. Av\u0161ak s novelizac\u00ed tohoto z\u00e1kona v prvn\u00edm roce \u00e9ry Reiwa (2019) byly zavedeny nov\u00e9 mechanismy, jako je syst\u00e9m pokut.<\/p>\n\n\n\n<p>V tomto \u010dl\u00e1nku se zam\u011b\u0159\u00edme na nov\u00e9 syst\u00e9my, reakce spr\u00e1vn\u00edch org\u00e1n\u016f na poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch a p\u0159edstav\u00edme konkr\u00e9tn\u00ed p\u0159\u00edklady.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_53 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Dva_typy_administrativnich_opatreni_a_jejich_uplatneni_v_ramci_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich_%E8%96%AC%E6%A9%9F%E6%B3%95\" title=\"Dva typy administrativn\u00edch opat\u0159en\u00ed a jejich uplatn\u011bn\u00ed v r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (\u85ac\u6a5f\u6cd5)\">Dva typy administrativn\u00edch opat\u0159en\u00ed a jejich uplatn\u011bn\u00ed v r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (\u85ac\u6a5f\u6cd5)<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Akty_vlady_ktere_vytvareji_pravni_prava_a_povinnosti_pro_jednotlivce\" title=\"Akty vl\u00e1dy, kter\u00e9 vytv\u00e1\u0159ej\u00ed pr\u00e1vn\u00ed pr\u00e1va a povinnosti pro jednotlivce\">Akty vl\u00e1dy, kter\u00e9 vytv\u00e1\u0159ej\u00ed pr\u00e1vn\u00ed pr\u00e1va a povinnosti pro jednotlivce<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Prostredky_pro_zajisteni_plneni_povinnosti_ulozenych_jednotlivcum\" title=\"Prost\u0159edky pro zaji\u0161t\u011bn\u00ed pln\u011bn\u00ed povinnost\u00ed ulo\u017een\u00fdch jednotlivc\u016fm\">Prost\u0159edky pro zaji\u0161t\u011bn\u00ed pln\u011bn\u00ed povinnost\u00ed ulo\u017een\u00fdch jednotlivc\u016fm<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Co_je_system_pokut_podle_japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich_Pharmaceuticals_and_Medical_Devices_Act\" title=\"Co je syst\u00e9m pokut podle japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (Pharmaceuticals and Medical Devices Act)\">Co je syst\u00e9m pokut podle japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (Pharmaceuticals and Medical Devices Act)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Priklady_spravnich_sankci_za_poruseni_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich\" title=\"P\u0159\u00edklady spr\u00e1vn\u00edch sankc\u00ed za poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch\">P\u0159\u00edklady spr\u00e1vn\u00edch sankc\u00ed za poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Priklad_1_Spolecnost_Pfizer_KK\" title=\"P\u0159\u00edklad 1: Spole\u010dnost Pfizer K.K.\">P\u0159\u00edklad 1: Spole\u010dnost Pfizer K.K.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Priklad_2_Spolecnost_Kansai_Medico_Co_Ltd\" title=\"P\u0159\u00edklad 2: Spole\u010dnost Kansai Medico Co., Ltd.\">P\u0159\u00edklad 2: Spole\u010dnost Kansai Medico Co., Ltd.<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Opatreni_k_dodrzovani_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich\" title=\"Opat\u0159en\u00ed k dodr\u017eov\u00e1n\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch\">Opat\u0159en\u00ed k dodr\u017eov\u00e1n\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch<\/a><ul class='ez-toc-list-level-3'><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Vytvoreni_internich_pokynu_ve_vasi_firme\" title=\"Vytvo\u0159en\u00ed intern\u00edch pokyn\u016f ve va\u0161\u00ed firm\u011b\">Vytvo\u0159en\u00ed intern\u00edch pokyn\u016f ve va\u0161\u00ed firm\u011b<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Konzultace_s_pravnikem\" title=\"Konzultace s pr\u00e1vn\u00edkem\">Konzultace s pr\u00e1vn\u00edkem<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Shrnuti_Pro_pravni_kontrolu_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich_Japanese_Pharmaceutical_and_Medical_Device_Act_se_obratte_na_pravnika\" title=\"Shrnut\u00ed: Pro pr\u00e1vn\u00ed kontrolu Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (Japanese Pharmaceutical and Medical Device Act) se obra\u0165te na pr\u00e1vn\u00edka\">Shrnut\u00ed: Pro pr\u00e1vn\u00ed kontrolu Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (Japanese Pharmaceutical and Medical Device Act) se obra\u0165te na pr\u00e1vn\u00edka<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/monolith.law\/cs\/general-corporate\/pmd-act-administrative-action\/#Predstaveni_opatreni_nasi_kancelare\" title=\"P\u0159edstaven\u00ed opat\u0159en\u00ed na\u0161\u00ed kancel\u00e1\u0159e\">P\u0159edstaven\u00ed opat\u0159en\u00ed na\u0161\u00ed kancel\u00e1\u0159e<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dva_typy_administrativnich_opatreni_a_jejich_uplatneni_v_ramci_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich_%E8%96%AC%E6%A9%9F%E6%B3%95\"><\/span>Dva typy administrativn\u00edch opat\u0159en\u00ed a jejich uplatn\u011bn\u00ed v r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (\u85ac\u6a5f\u6cd5)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Japonsk\u00fd z\u00e1kon o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (\u85ac\u6a5f\u6cd5) m\u00e1 za c\u00edl zlep\u0161it ve\u0159ejn\u00e9 zdrav\u00ed t\u00edm, \u017ee stanov\u00ed pot\u0159ebn\u00e1 opat\u0159en\u00ed a regulace pro zaji\u0161t\u011bn\u00ed kvality, \u00fa\u010dinnosti a bezpe\u010dnosti l\u00e9\u010div a dal\u0161\u00edch produkt\u016f a pro prevenci vzniku a \u0161\u00ed\u0159en\u00ed zdravotn\u00edch rizik (\u010dl\u00e1nek 1 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch).<\/p>\n\n\n\n<p>Tato opat\u0159en\u00ed lze rozd\u011blit na dv\u011b hlavn\u00ed kategorie: \u2460 akty, kter\u00e9 vytv\u00e1\u0159ej\u00ed pr\u00e1va a povinnosti pro jednotlivce jako d\u016fsledek pr\u00e1vn\u00edch p\u0159edpis\u016f ze strany vl\u00e1dy, a \u2461 prost\u0159edky pro zaji\u0161t\u011bn\u00ed pln\u011bn\u00ed povinnost\u00ed ulo\u017een\u00fdch t\u011bmito akty.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Akty_vlady_ktere_vytvareji_pravni_prava_a_povinnosti_pro_jednotlivce\"><\/span>Akty vl\u00e1dy, kter\u00e9 vytv\u00e1\u0159ej\u00ed pr\u00e1vn\u00ed pr\u00e1va a povinnosti pro jednotlivce<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Tyto akty lze d\u00e1le rozd\u011blit na &#8216;p\u0159\u00edkazov\u00e9 akty&#8217;, kter\u00e9 na\u0159izuj\u00ed jednotlivc\u016fm konat nebo nekonat, &#8216;formuj\u00edc\u00ed akty&#8217;, kter\u00e9 vytv\u00e1\u0159ej\u00ed pr\u00e1vn\u00ed postaven\u00ed pro jednotlivce, a &#8216;ur\u010dovac\u00ed akty&#8217;, kter\u00e9 ur\u010duj\u00ed pr\u00e1vn\u00ed vztahy t\u00fdkaj\u00edc\u00ed se jednotlivc\u016f.<img decoding=\"async\" style=\"width: 735px\" src=\"https:\/\/lh4.googleusercontent.com\/mbTpbO66cqHaRY3tMUdG1ffRyskCEleqJ61clS663dkeldZ-oIiXXnZHUKp4L2LGUCIm1ysYzxl8zxQ4OFTWe4uI_5JDbAKHUgOSfNUAaMNbiURjq_4onSBDtKhWEMNcwrMx9C8EsK_IxA21mmPWeVU\"><\/p>\n\n\n\n<p>(Citace: <a href=\"https:\/\/www.mhlw.go.jp\/content\/10601000\/000477356.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Materi\u00e1ly z 3. zased\u00e1n\u00ed v\u00fdboru pro l\u00e9\u010diva a zdravotnick\u00e9 prost\u0159edky ze dne 7. \u010dervna 2018 (Heisei 30)[ja]<\/a>)<\/p>\n\n\n\n<p>V r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch jsou stanoveny p\u0159\u00edkazov\u00e9 akty, jako jsou p\u0159\u00edkazy k vylep\u0161en\u00ed metod kvality a bezpe\u010dnostn\u00edho \u0159\u00edzen\u00ed (\u010dl\u00e1nek 72, odstavec 1), p\u0159\u00edkazy k zastaven\u00ed poru\u0161ov\u00e1n\u00ed z\u00e1kona (\u010dl\u00e1nek 72-5, odstavec 1), p\u0159\u00edkazy k zastaven\u00ed \u010dinnosti (\u010dl\u00e1nek 72, odstavec 1, \u010dl\u00e1nek 75, odstavec 1 atd.).<\/p>\n\n\n\n<p>Obzvl\u00e1\u0161t\u011b opat\u0159en\u00ed v podob\u011b p\u0159\u00edkaz\u016f k zastaven\u00ed poru\u0161ov\u00e1n\u00ed z\u00e1kona (\u010dl\u00e1nek 72-5 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch) byla roz\u0161\u00ed\u0159ena o dal\u0161\u00ed poru\u0161en\u00ed z\u00e1kona v d\u016fsledku zm\u011bn v roce 2019 (Reiwa 1).<\/p>\n\n\n\n<p>Pro v\u00edce informac\u00ed o zm\u011bn\u00e1ch Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch v roce 2019 (Reiwa 1), v\u010detn\u011b opat\u0159en\u00ed v podob\u011b p\u0159\u00edkaz\u016f, se pod\u00edvejte na n\u00e1sleduj\u00edc\u00ed \u010dl\u00e1nek.<\/p>\n\n\n\n<p>Souvisej\u00edc\u00ed \u010dl\u00e1nek: <a href=\"https:\/\/monolith.law\/?p=49827\" target=\"_blank\" rel=\"noreferrer noopener\">Obsah zm\u011bn Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch v roce 2019 (Reiwa 1) &#8211; budoucnost l\u00e9k\u00e1ren a l\u00e9k\u00e1rn\u00edk\u016f, syst\u00e9m pokut[ja]<\/a><\/p>\n\n\n\n<p>Co se t\u00fd\u010de formuj\u00edc\u00edch akt\u016f, Japonsk\u00fd z\u00e1kon o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch stanovuje nap\u0159\u00edklad schv\u00e1len\u00ed provozn\u00edch postup\u016f registrovan\u00fdch certifika\u010dn\u00edch org\u00e1n\u016f (\u010dl\u00e1nek 23-10, odstavec 1) nebo zru\u0161en\u00ed povolen\u00ed pro v\u00fdrobu a prodej (\u010dl\u00e1nek 75, odstavec 1).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Prostredky_pro_zajisteni_plneni_povinnosti_ulozenych_jednotlivcum\"><\/span>Prost\u0159edky pro zaji\u0161t\u011bn\u00ed pln\u011bn\u00ed povinnost\u00ed ulo\u017een\u00fdch jednotlivc\u016fm<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Co se t\u00fd\u010de v\u00fd\u0161e uveden\u00fdch akt\u016f, i kdy\u017e vl\u00e1da vyd\u00e1 p\u0159\u00edkaz k vylep\u0161en\u00ed metod kvality a bezpe\u010dnostn\u00edho \u0159\u00edzen\u00ed pro v\u00fdrobce a prodejce l\u00e9\u010div, to samo o sob\u011b neznamen\u00e1, \u017ee se metody kvality a bezpe\u010dnostn\u00edho \u0159\u00edzen\u00ed skute\u010dn\u011b vylep\u0161\u00ed. Povinnost je spln\u011bna pouze tehdy, kdy\u017e v\u00fdrobce a prodejce, kter\u00fdm byl vyd\u00e1n p\u0159\u00edkaz, skute\u010dn\u011b podniknou kroky k vylep\u0161en\u00ed.<\/p>\n\n\n\n<p>Proto jsou v z\u00e1kon\u011b stanoveny metody, jak vl\u00e1da m\u016f\u017ee vynutit pln\u011bn\u00ed povinnost\u00ed jednotlivci, a sankce za poru\u0161en\u00ed povinnost\u00ed.<\/p>\n\n\n\n<p>V r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch jsou ji\u017e dlouho stanoveny tresty jako v\u011bzen\u00ed nebo pokuty (\u010dl\u00e1nek 83-6 a n\u00e1sleduj\u00edc\u00ed), administrativn\u00ed pokuty (\u010dl\u00e1nek 91) atd. Syst\u00e9m pokut, kter\u00fd byl nov\u011b zaveden zm\u011bnami v roce 2019 (Reiwa 1), je tak\u00e9 pova\u017eov\u00e1n za sankci za poru\u0161en\u00ed povinnost\u00ed (\u010dl\u00e1nek 75-5-2 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Co_je_system_pokut_podle_japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich_Pharmaceuticals_and_Medical_Devices_Act\"><\/span>Co je syst\u00e9m pokut podle japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (Pharmaceuticals and Medical Devices Act)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Pokuta je finan\u010dn\u00ed z\u00e1t\u011b\u017e ulo\u017een\u00e1 poru\u0161iteli. Existuje podobn\u00e1 finan\u010dn\u00ed z\u00e1t\u011b\u017e, kterou naz\u00fdv\u00e1me &#8220;pokuta&#8221;, ale pokuta je jedn\u00edm z trest\u016f stanoven\u00fdch v trestn\u00edm z\u00e1kon\u011b a pokud je ulo\u017eena, st\u00e1v\u00e1 se z n\u00ed trestn\u00fd rejst\u0159\u00edk. Na druhou stranu, pokuta je pova\u017eov\u00e1na za administrativn\u00ed trest a skute\u010dnost, \u017ee byl vyd\u00e1n p\u0159\u00edkaz k jeho zaplacen\u00ed, se nest\u00e1v\u00e1 trestn\u00fdm rejst\u0159\u00edkem.<\/p>\n\n\n\n<p>Jedn\u00edm z d\u016fvod\u016f pro zaveden\u00ed syst\u00e9mu pokut bylo, \u017ee maxim\u00e1ln\u00ed v\u00fd\u0161e pokuty stanoven\u00e9 v minulosti byla 2 miliony jen\u016f, co\u017e je mal\u00e1 \u010d\u00e1stka ve srovn\u00e1n\u00ed s p\u0159\u00edjmy z poru\u0161en\u00ed japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch.<\/p>\n\n\n\n<p>Byly vzneseny kritiky na tento syst\u00e9m, \u017ee jeho odstra\u0161uj\u00edc\u00ed \u00fa\u010dinek na poru\u0161en\u00ed je nedostate\u010dn\u00fd a \u017ee by m\u011bl b\u00fdt odebr\u00e1n neopr\u00e1vn\u011bn\u00fd zisk. Proto syst\u00e9m pokut stanovuje v\u00fd\u0161i pokuty na 4,5% z p\u0159\u00edjm\u016f z poru\u0161en\u00ed a finan\u010dn\u00ed z\u00e1t\u011b\u017e je ulo\u017eena v souladu s poru\u0161en\u00edm.<\/p>\n\n\n\n<p>Nav\u00edc, neexistuje \u017e\u00e1dn\u00fd maxim\u00e1ln\u00ed limit pro v\u00fd\u0161i pokuty. Proto spole\u010dnosti, kter\u00e9 prod\u00e1vaj\u00ed l\u00e9ky a podobn\u00e9 produkty pomoc\u00ed neleg\u00e1ln\u00ed reklamy, jako je fale\u0161n\u00e1 a p\u0159ehnan\u00e1 reklama, mohou \u010delit velk\u00e9 finan\u010dn\u00ed z\u00e1t\u011b\u017ei, a proto je t\u0159eba p\u0159i reklam\u011b na l\u00e9ky a podobn\u00e9 produkty pe\u010dliv\u011b zkontrolovat, zda nedoch\u00e1z\u00ed k poru\u0161en\u00ed z\u00e1kona.<\/p>\n\n\n\n<p>Pro v\u00edce podrobnost\u00ed o v\u00fdpo\u010dtu pokut a dal\u0161\u00edch podrobnost\u00ed, pros\u00edm, viz n\u00e1sleduj\u00edc\u00ed \u010dl\u00e1nek.<\/p>\n\n\n\n<p>Souvisej\u00edc\u00ed \u010dl\u00e1nek: <a href=\"https:\/\/monolith.law\/?p=49848\" target=\"_blank\" rel=\"noreferrer noopener\">Co je syst\u00e9m pokut podle japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch? Vysv\u011btlen\u00ed \u010dinnost\u00ed, kter\u00e9 jsou p\u0159edm\u011btem a p\u0159\u00edpady sn\u00ed\u017een\u00ed[ja]<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Priklady_spravnich_sankci_za_poruseni_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich\"><\/span>P\u0159\u00edklady spr\u00e1vn\u00edch sankc\u00ed za poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2023\/03\/Shutterstock_707565829.jpg\" alt=\"P\u0159\u00edklady spr\u00e1vn\u00edch sankc\u00ed za poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch\" class=\"wp-image-60055\" \/><\/figure>\n\n\n\n<p>Pokud je proti spole\u010dnostem, kter\u00e9 poru\u0161ily Japonsk\u00fd z\u00e1kon o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch, uplatn\u011bna spr\u00e1vn\u00ed sankce, Ministerstvo zdravotnictv\u00ed, pr\u00e1ce a soci\u00e1ln\u00edch v\u011bc\u00ed a dal\u0161\u00ed org\u00e1ny vyd\u00e1vaj\u00ed tiskov\u00e9 zpr\u00e1vy. N\u00ed\u017ee uv\u00e1d\u00edme p\u0159\u00edklad spr\u00e1vn\u00ed sankce, kter\u00e1 byla uplatn\u011bna proti spole\u010dnosti.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Priklad_1_Spolecnost_Pfizer_KK\"><\/span>P\u0159\u00edklad 1: Spole\u010dnost Pfizer K.K.<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>V z\u00e1\u0159\u00ed 2015 byl v\u016f\u010di spole\u010dnosti Pfizer K.K. vyd\u00e1n p\u0159\u00edkaz k vylep\u0161en\u00ed provozu (\u010dl\u00e1nek 72 odstavec 4 bod 1 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch).<\/p>\n\n\n\n<p>V\u00fdrobci a prodejci l\u00e9\u010div maj\u00ed povinnost nahl\u00e1sit ministrovi zdravotnictv\u00ed, pr\u00e1ce a soci\u00e1ln\u00edch v\u011bc\u00ed p\u0159\u00edpady podez\u0159en\u00ed na vedlej\u0161\u00ed \u00fa\u010dinky v ur\u010dit\u00e9m \u010dasov\u00e9m obdob\u00ed (\u010dl\u00e1nek 68 odstavec 10 a \u010dl\u00e1nek 228 odstavec 20 prov\u00e1d\u011bc\u00edho na\u0159\u00edzen\u00ed k Japonsk\u00e9mu z\u00e1konu o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch). V tomto p\u0159\u00edpad\u011b bylo probl\u00e9mem, \u017ee spole\u010dnost Pfizer K.K., kter\u00e1 vyr\u00e1b\u00ed a prod\u00e1v\u00e1 11 druh\u016f l\u00e9k\u016f, v\u010detn\u011b l\u00e9k\u016f proti rakovin\u011b, nepodala zpr\u00e1vu o 212 p\u0159\u00edpadech vedlej\u0161\u00edch \u00fa\u010dink\u016f, o kter\u00fdch v\u011bd\u011bla, v dan\u00e9m \u010dasov\u00e9m obdob\u00ed.<\/p>\n\n\n\n<p>Vzhledem k tomu, \u017ee v tomto p\u0159\u00edpad\u011b nebyla zpr\u00e1va o vedlej\u0161\u00edch \u00fa\u010dinc\u00edch pod\u00e1na zodpov\u011bdn\u00fdm pracovn\u00edkem pro informace o l\u00e9\u010divech do odd\u011blen\u00ed pro dohled nad bezpe\u010dnost\u00ed, bylo v r\u00e1mci p\u0159\u00edkazu k vylep\u0161en\u00ed provozu na\u0159\u00edzeno p\u0159epracov\u00e1n\u00ed postup\u016f pro dohled nad bezpe\u010dnost\u00ed, vzd\u011bl\u00e1v\u00e1n\u00ed a \u0161kolen\u00ed zam\u011bstnanc\u016f, p\u0159edlo\u017een\u00ed pl\u00e1nu na zlep\u0161en\u00ed opat\u0159en\u00ed pro n\u00e1pravu a prevenci opakov\u00e1n\u00ed.<\/p>\n\n\n\n<p>Odkaz: <a href=\"https:\/\/www.mhlw.go.jp\/stf\/houdou\/0000094443.html\" target=\"_blank\" rel=\"noreferrer noopener\">Spr\u00e1vn\u00ed sankce proti poru\u0161itel\u016fm Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch | Ministerstvo zdravotnictv\u00ed, pr\u00e1ce a soci\u00e1ln\u00edch v\u011bc\u00ed[ja]<\/a><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Priklad_2_Spolecnost_Kansai_Medico_Co_Ltd\"><\/span>P\u0159\u00edklad 2: Spole\u010dnost Kansai Medico Co., Ltd.<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>V b\u0159eznu 2017 byly v\u016f\u010di spole\u010dnosti Kansai Medico Co., Ltd. vyd\u00e1ny p\u0159\u00edkazy k vylep\u0161en\u00ed provozu (\u010dl\u00e1nek 72 odstavec 4 bod 1 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch) a k zastaven\u00ed provozu (\u010dl\u00e1nek 75 odstavec 1 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch) od prefektury Nara a m\u011bsta Nara.<\/p>\n\n\n\n<p>Jedn\u00e1 se o p\u0159\u00edpad, kdy byly v l\u00e9k\u00e1rn\u011b p\u0159edeps\u00e1ny pad\u011blan\u00e9 tablety &#8220;Harvoni&#8221; pro l\u00e9\u010dbu hepatitidy C a byly distribuov\u00e1ny pacient\u016fm.<\/p>\n\n\n\n<p>Prodejn\u011b, kter\u00e1 nakoupila pad\u011blan\u00e9 zbo\u017e\u00ed, byl vyd\u00e1n p\u0159\u00edkaz k zastaven\u00ed provozu a zm\u011bn\u011b spr\u00e1vce (\u010dl\u00e1nek 73 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch) z d\u016fvodu n\u00e1kupu a skladov\u00e1n\u00ed pad\u011blan\u00e9ho zbo\u017e\u00ed za \u00fa\u010delem prodeje a poskytnut\u00ed jin\u00fdm prodejn\u00e1m (poru\u0161en\u00ed \u010dl\u00e1nku 55 odstavec 2 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch), nespr\u00e1vn\u00e9ho \u0159\u00edzen\u00ed n\u00e1kupu a distribuce l\u00e9\u010div spr\u00e1vcem (poru\u0161en\u00ed \u010dl\u00e1nku 7 odstavec 2 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch) a nespr\u00e1vn\u00e9ho proveden\u00ed test\u016f a inspekc\u00ed l\u00e9\u010div spr\u00e1vcem p\u0159i n\u00e1kupu, p\u0159esto\u017ee nebyly k dispozici krabice ani p\u0159ilo\u017een\u00e9 dokumenty (poru\u0161en\u00ed \u010dl\u00e1nku 9 odstavec 1 Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch).<\/p>\n\n\n\n<p>Krom\u011b toho byl vyd\u00e1n p\u0159\u00edkaz k vylep\u0161en\u00ed provozu v\u016f\u010di dv\u011bma prodejn\u00e1m, kter\u00e9 obdr\u017eely pad\u011blan\u00e9 zbo\u017e\u00ed od dodavatele, vzhledem k syst\u00e9mu \u0159\u00edzen\u00ed l\u00e9\u010div a dohledu nad provozovatelem l\u00e9k\u00e1rny.<\/p>\n\n\n\n<p>Odkaz: <a href=\"https:\/\/www.mhlw.go.jp\/file\/04-Houdouhappyou-11126000-Iyakushokuhinkyoku-Kanshishidoumayakutaisakuka\/0000154073.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Reakce na pad\u011blan\u00e9 tablety &#8220;Harvoni&#8221; pro l\u00e9\u010dbu hepatitidy C, kter\u00e9 byly objeveny v prefektu\u0159e (5. zpr\u00e1va) (Tiskov\u00e1 zpr\u00e1va prefektury Nara)[ja]<\/a><\/p>\n\n\n\n<p>Odkaz: <a href=\"https:\/\/www.mhlw.go.jp\/file\/04-Houdouhappyou-11126000-Iyakushokuhinkyoku-Kanshishidoumayakutaisakuka\/170316_press_nara.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Reakce na pad\u011blan\u00e9 tablety &#8220;Harvoni&#8221; pro l\u00e9\u010dbu hepatitidy C, kter\u00e9 byly objeveny v prefektu\u0159e (6. zpr\u00e1va) (Tiskov\u00e1 zpr\u00e1va prefektury Nara)[ja]<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Opatreni_k_dodrzovani_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich\"><\/span>Opat\u0159en\u00ed k dodr\u017eov\u00e1n\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Jak jsme ji\u017e uvedli, pokud dojde k poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch, m\u016f\u017ee b\u00fdt na\u0159\u00edzena spr\u00e1vn\u00ed sankce a skute\u010dnost poru\u0161en\u00ed z\u00e1kona a obsah spr\u00e1vn\u00edch sankc\u00ed mohou b\u00fdt zve\u0159ejn\u011bny. To m\u016f\u017ee v\u00e9st nejen k finan\u010dn\u00ed z\u00e1t\u011b\u017ei, ale tak\u00e9 k ztr\u00e1t\u011b d\u016fv\u011bryhodnosti va\u0161\u00ed firmy.<\/p>\n\n\n\n<p>Jak\u00e9 opat\u0159en\u00ed tedy m\u016f\u017eete p\u0159ijmout, abyste nedo\u0161lo k poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch?<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Vytvoreni_internich_pokynu_ve_vasi_firme\"><\/span>Vytvo\u0159en\u00ed intern\u00edch pokyn\u016f ve va\u0161\u00ed firm\u011b<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Jedn\u00edm z opat\u0159en\u00ed je vytvo\u0159en\u00ed intern\u00edch pokyn\u016f ve va\u0161\u00ed firm\u011b. Je t\u0159eba si uv\u011bdomit, jak\u00e9 \u010diny mohou v\u00e9st k poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch, a to nejen prost\u0159ednictv\u00edm kontroly z\u00e1konn\u00fdch ustanoven\u00ed, ale tak\u00e9 prost\u0159ednictv\u00edm pochopen\u00ed obsahu r\u016fzn\u00fdch pokyn\u016f a ozn\u00e1men\u00ed vyd\u00e1van\u00fdch Ministerstvem zdravotnictv\u00ed, pr\u00e1ce a soci\u00e1ln\u00edch v\u011bc\u00ed. Z\u00edsk\u00e1n\u00ed pot\u0159ebn\u00fdch informac\u00ed z t\u011bchto zdroj\u016f m\u016f\u017ee b\u00fdt n\u00e1ro\u010dn\u00e9.<\/p>\n\n\n\n<p>Proto je d\u016fle\u017eit\u00e9 sd\u00edlet v r\u00e1mci firmy intern\u00ed pokyny, kter\u00e9 stanov\u00ed, jak by m\u011bly b\u00fdt prov\u00e1d\u011bny \u010dinnosti, kter\u00e9 by mohly v\u00e9st k poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch. T\u00edmto zp\u016fsobem m\u016f\u017eete upozornit ka\u017ed\u00e9ho zam\u011bstnance na mo\u017en\u00e9 poru\u0161en\u00ed tohoto z\u00e1kona.<\/p>\n\n\n\n<p>Co se t\u00fd\u010de reklamy na l\u00e9ky a podobn\u00e9 produkty, je d\u016fle\u017eit\u00e9, aby nejen v\u00fdrobci a prodejci, ale tak\u00e9 reklamn\u00ed agentury byly opatrn\u00e9, aby nedo\u0161lo k poru\u0161en\u00ed Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch. Pokud budete schopni sd\u011blit sv\u00fdm obchodn\u00edm partner\u016fm, na co by m\u011bli d\u00e1vat pozor, pravd\u011bpodobnost poru\u0161en\u00ed tohoto z\u00e1kona se sn\u00ed\u017e\u00ed.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Konzultace_s_pravnikem\"><\/span>Konzultace s pr\u00e1vn\u00edkem<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>P\u0159i vytv\u00e1\u0159en\u00ed intern\u00edch pokyn\u016f je d\u016fle\u017eit\u00e9 konzultovat se s pr\u00e1vn\u00edkem, kter\u00fd je obezn\u00e1men s Japonsk\u00fdm z\u00e1konem o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch, pokud m\u00e1te obavy, zda jste spr\u00e1vn\u011b vybrali informace, na kter\u00e9 byste se m\u011bli odkazovat, nebo zda jsou va\u0161e intern\u00ed pokyny dostate\u010dn\u00e9. I kdy\u017e je t\u011b\u017ek\u00e9 definitivn\u011b ur\u010dit, zda ur\u010dit\u00e1 \u010dinnost spad\u00e1 pod regulaci tohoto z\u00e1kona, m\u016f\u017eete o\u010dek\u00e1vat pr\u00e1vn\u00ed radu zalo\u017eenou na pr\u00e1vn\u00edm pohledu a zku\u0161enostech pr\u00e1vn\u00edka.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Shrnuti_Pro_pravni_kontrolu_Japonskeho_zakona_o_lecivech_a_zdravotnickych_prostredcich_Japanese_Pharmaceutical_and_Medical_Device_Act_se_obratte_na_pravnika\"><\/span>Shrnut\u00ed: Pro pr\u00e1vn\u00ed kontrolu Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (Japanese Pharmaceutical and Medical Device Act) se obra\u0165te na pr\u00e1vn\u00edka<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/monolith.law\/wp-content\/uploads\/2023\/03\/Shutterstock_2129385929.jpg\" alt=\"Shrnut\u00ed: M\u00e1te probl\u00e9my s Japonsk\u00fdm z\u00e1konem o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch? Obra\u0165te se na pr\u00e1vn\u00edka\" class=\"wp-image-60056\" \/><\/figure>\n\n\n\n<p>Ur\u010den\u00ed, kter\u00e9 \u010diny poru\u0161uj\u00ed Japonsk\u00fd z\u00e1kon o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch, m\u016f\u017ee b\u00fdt v n\u011bkter\u00fdch p\u0159\u00edpadech jasn\u011b rozhodnuto jednotliv\u00fdmi spole\u010dnostmi, zat\u00edmco v jin\u00fdch p\u0159\u00edpadech m\u016f\u017ee b\u00fdt rozhodnut\u00ed, zda je n\u011bco leg\u00e1ln\u00ed nebo neleg\u00e1ln\u00ed, obt\u00ed\u017en\u00e9. Pokud m\u00e1te obavy, zda va\u0161e sou\u010dasn\u00e1 nebo budouc\u00ed \u010dinnost poru\u0161uje Japonsk\u00fd z\u00e1kon o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch, obra\u0165te se na pr\u00e1vn\u00edka.<\/p>\n\n\n\n<p>Pr\u00e1vn\u00ed kontrola a n\u00e1vrhy na p\u0159eformulov\u00e1n\u00ed v\u00fdraz\u016f v r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch jsou velmi specializovan\u00e9 oblasti. Na\u0161e pr\u00e1vn\u00ed kancel\u00e1\u0159 Monolith m\u00e1 t\u00fdm specializovan\u00fd na Japonsk\u00fd z\u00e1kon o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch a je p\u0159ipravena poskytnout kontrolu \u010dl\u00e1nk\u016f pro \u0161irokou \u0161k\u00e1lu produkt\u016f, od dopl\u0148k\u016f stravy po l\u00e9\u010diva.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Predstaveni_opatreni_nasi_kancelare\"><\/span>P\u0159edstaven\u00ed opat\u0159en\u00ed na\u0161\u00ed kancel\u00e1\u0159e<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Pr\u00e1vnick\u00e1 kancel\u00e1\u0159 Monolith je pr\u00e1vnick\u00e1 kancel\u00e1\u0159 s bohat\u00fdmi zku\u0161enostmi v oblasti IT, zejm\u00e9na internetu a pr\u00e1va. Na\u0161e kancel\u00e1\u0159 poskytuje slu\u017eby, jako je pr\u00e1vn\u00ed kontrola \u010dl\u00e1nk\u016f a landing pages, vytv\u00e1\u0159en\u00ed pokyn\u016f a kontrola vzork\u016f pro provozovatele m\u00e9di\u00ed, provozovatele recenzn\u00edch str\u00e1nek, reklamn\u00ed agentury, v\u00fdrobce dopl\u0148k\u016f stravy a kosmetiky, kliniky, provozovatele ASP a dal\u0161\u00ed v oblasti D2C. Podrobnosti jsou uvedeny v n\u00e1sleduj\u00edc\u00edm \u010dl\u00e1nku.<\/p>\n\n\n\n<p>Obory, kter\u00fdmi se zab\u00fdv\u00e1 pr\u00e1vnick\u00e1 kancel\u00e1\u0159 Monolith: <a href=\"https:\/\/monolith.law\/operationofmedia\" target=\"_blank\" rel=\"noreferrer noopener\">Kontrola \u010dl\u00e1nk\u016f a landing pages podle japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch p\u0159\u00edstroj\u00edch[ja]<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>V r\u00e1mci Japonsk\u00e9ho z\u00e1kona o l\u00e9\u010divech a zdravotnick\u00fdch prost\u0159edc\u00edch (\u85ac\u6a5f\u6cd5) byly ji\u017e d\u0159\u00edve stanoveny spr\u00e1vn\u00ed sankce, jako jsou p\u0159\u00edkazy k vylep\u0161en\u00ed podnik\u00e1n\u00ed pro v\u00fdrobce a prodejce l\u00e9\u010div a dal\u0161\u00edch produkt [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":64246,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[30,24],"acf":[],"_links":{"self":[{"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/posts\/61145"}],"collection":[{"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/comments?post=61145"}],"version-history":[{"count":2,"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/posts\/61145\/revisions"}],"predecessor-version":[{"id":64247,"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/posts\/61145\/revisions\/64247"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/media\/64246"}],"wp:attachment":[{"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/media?parent=61145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/categories?post=61145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/monolith.law\/cs\/wp-json\/wp\/v2\/tags?post=61145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}